生命科学资讯

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease

After years of debate, the Biosecure Act could be headed for Trump’s desk

Chinese researchers divulge new WRN inhibitors

Minova Pharmaceutical and Precision Brain Science describe new salts of deuterated dextromethorphan

New KIF18A inhibitors disclosed in Inventisbio patent

Apollo AP45 discovers new PERK inhibitors

Lonza CHI: Organic capsules for next-gen plant-based nutraceuticals - nutritioninsight.com

AI biotech Chai Discovery raises $130M Series B at $1.3B valuation

Western genetic medicine makers turn to Chinese investigator-initiated trials

Marex Group plc Makes New $1.24 Million Investment in Illumina, Inc. $ILMN - MarketBeat

Argenx cans thyroid eye disease trials of Vyvgart Hytrulo

10x Genomics price target raised to $22 from $17 at Barclays - TipRanks

Mortuary Refrigerator Market Is Going to Boom |• Thermo Fisher Scientific • Pelican BioThermal - openPR.com

Barclays Upgrades Agilent Technologies to Overweight From Equalweight, Price Target is $165 - marketscreener.com

Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com

National Bank of Canada FI Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress

Sobi to buy gout biotech Arthrosi for $950M upfront

Beyond the ADC Hype: Innovation is accelerating through bispecifics and dual payload strategies

How Agilent’s New GMP-Ready xCELLigence Software Could Reshape Agilent Technologies (A) Investors’ Outlook - simplywall.st